Bayer Veterinary Care Usage Study

Feline Findings

Key Discovery: Feline care represents about 80% of the growth potential for veterinary practices.

About the Bayer Veterinary Care Usage Study

Phase I

The first phase of the study focused on the decline in veterinary usage from the pet owner's perspective, identifying six root causes: the economic impact of the recession; fragmentation of veterinary services; the use of the Internet versus office visits; feline resistance; perception that regular medical check-ups are unnecessary and cost of care.


Phase II

The second phase found a major divide between pet owners and veterinarians when it came to ensuring pets remain healthy. Nearly all veterinarians believe that pets require at least one veterinary well-visit annually, but two-thirds of them also believe pet owners don’t value these exams.


Phase III

The key objectives of the third phase were to: conduct further research regarding feline-specific reasons for the decline in veterinary visits; determine the extent to which veterinary practices recognize the need to improve cat care and what steps, if any, they have taken to increase their feline visits; and identify opportunities which practices can apply to increase feline visits. Read about the findings.

Bayer LogoAmerican Association of Feline Practitioners LogoBrakke Consulting, Inc. LogoNational Commission on Veterinary Economic Issues Logo

  1.  von Simson C, Volk J, Felsted KE. (2011). Bayer Veterinary Care Usage Study: The Decline of Veterinary Visits and How to Reverse the Trend.  Presented at: AVMA Annual Convention, July 2011; St.Louis, MO. Slide 68.

 

 

Important Safety Information

 

Advantage Multi® for Cats (imidacloprid + moxidectin) Topical Solution
WARNINGS: Do not use on sick, debilitated, or underweight cats. Do not use on cats less than 9 weeks of age or less than 2 lbs. body weight.PRECAUTION: Avoid oral ingestion. HUMAN WARNINGS: Children should not contact application site for 30 minutes. CAUTION: Federal (U.S.A.) law restricts this drug  to use by or on the order of a licensed veterinarian Additional Safety Information.

Profender® (emodepside/praziquantel)
HUMAN WARNINGS: Children should not contact application site for twenty-four (24) hours. PRECAUTIONS: Oral ingestion or exposure should be avoided. Use with caution in sick or debilitated cats. CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. Additional Safety Information

Veraflox® (pradofloxacin) Oral Suspension for Cats
CONTRAINDICATION: Do not use in dogs. WARNING: For use in cats only. PRECAUTION: The use of fluoroquinolones in cats has been associated with the development of retinopathy and/or blindness. Such products should be used with caution in cats. The safety of pradofloxacin in cats younger than 12 weeks of age has not been evaluated. The safety of pradofloxacin in cats that are used for breeding or that are pregnant and/or lactating has not been evaluated. Quinolones have been shown to produce erosions of cartilage of weight-bearing joints and other signs of arthropathy in immature animals of various species. The safety of pradofloxacin in immune-compromised cats (i.e., cats infected with feline leukemia virus and/or feline immune-deficiency virus) has not been evaluated. Quinolones should be used with caution in animals with known or suspected central nervous system (CNS) disorders. In such animals, quinolones have, in rare instances, been associated with CNS stimulation that may lead to convulsive seizures.
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Federal law prohibits the extra label use of this drug in food-producing animals.Additional Safety Information

Advantage Multi®, Profender®, and Veraflox® are registered trademarks of Bayer.
 

Copyright© Bayer HealthCare LLC, Animal Health
Bayer and the Bayer Cross are registered trademarks of Bayer.